Inizio Evoke spent years collecting specialist agencies. Then it made the unusual admission that the collection had become the problem - and began turning a maze of names into one healthcare commercialization machine.
Calcium+Company built a health-marketing group around a surprisingly sticky idea: brands, like bodies, need more than one nutrient. The interesting part is not the pun. It is the operating model hiding underneath it.
A drug can work perfectly and still fail to reach patients. OPEN Health built a global consultancy around the awkward middle - the evidence, access, education, and human judgment that turn a scientific result into a confident decision.
A health campaign has to satisfy the scientist, the regulator, the payer, the physician, the patient, and the person scrolling at lunch. Ogilvy Health built one company to keep all six in the room.
Citrus Health Group bought its way across the pharmaceutical launch journey. The clever part is not owning every specialty - it is deciding when each one enters the room.
A private-equity transition dented revenue. RevHealth's answer was not a louder campaign, but a quieter reinvention of the agency workflow - putting medical, access, creative and AI in the same room before the brief hardens.
Publicis Health built a global machine for making medicine understandable. Then a $350 million settlement made the industry confront a harder question: what happens when the machine works too well?
Four specialist agencies, nine capabilities and one expensive promise: that a drug launch gets smarter when the scientists, creatives, data analysts and access strategists stop passing the brief around.
MEYA Health works in the awkward distance between scientific approval and real-world access - where evidence must become a story that payers, health systems and field teams can actually use.
The agency’s sharpest ideas did not ask people to learn a new behavior. They hid better health inside habits people already trusted - a bracelet, a loaf of bread, a breath into a phone.
A growth-marketing agency, an industrial sales platform and a sustainability-minded shop sit in WOLGroup’s orbit. Their common problem: helping a good product find its next buyer.
Hyderabad did not merely commission an incubator. It built a piece of civic machinery where founders, corporates, investors, universities and government are expected to collide - then turn those collisions into companies.
In Gard and Hérault, an entrepreneur-run association turns national startup programs into local introductions. Its real test is what happens after the handshake.
Abu Dhabi’s startup hub offers cash, subsidized services and introductions to people who can buy what founders build. The bargain asks something in return: equity, commitment and a reason to stay.
In Malaysia, BEYOND4 connects skills training, startup programmes and routes into new markets. Its Pahang experiment shows why building the people can come before building the company.
Catalonia can produce the science. Getting it into everyday care is another job. Biocat is building the connections, training and routes into the health system that make that journey possible.
Malaysia has grants, investors and plenty of ambition. MYStartup’s job is to help founders find the right support - then turn that introduction into a business.
From Jordanian suppliers to Tunisian tourism, the nonprofit connects business support to buyers and jobs. Its projects show what that takes - and its accounts show the financial strain behind the work.
A suitcase delivery startup shows what Intelak can offer beyond a grant: a route into the companies that run travel. Dubai’s incubator and accelerator now applies that approach to everything from cargo handling to the airport lounge.
The trade association runs an equity-free incubator, connects founders with investors and helps overseas startups find their feet. Its real proposition is access - with homework attached.
After eight earlier ventures, Ghassan Halawa built a company to help other founders. From Palestinian startups entering Saudi Arabia to PepsiCo’s youth hackathons, Parachute16 makes a business of getting people ready for their next move.
In South Africa, a township-based incubator puts business coaching, production tools and industry connections within reach of creative entrepreneurs. Its real test begins when the training ends and the invoices should start.
At the Indian School of Business in Mohali, startup support gets practical: build the prototype, find a pilot, and work out who will pay. The price of that help depends on which door a founder walks through.
Born out of a Singapore sugar manufacturer, Innovate360 helps founders turn food experiments into products they can manufacture, distribute and sell. Its latest stop is the shop floor on Orchard Road.
The Hong Kong accelerator began with the messy business of making hardware. Its next test is turning corporate introductions into working pilots - with very different prices for admission.
A Singapore delivery startup needed a foothold in Mumbai. Startup Réseau helped it test demand and make local connections - a revealing example of how this consulting company turns market access into practical work.
In Casablanca, Mehdi Alaoui’s accelerator brings young companies into the orbit of corporate buyers. Its next test: helping Moroccan education startups reach learners who are too often left out.
The healthcare-data unicorn spent a decade stitching together patient journeys. Its harder problem was turning that expensive map into answers that scientists, sales teams and regulators could actually use.
How a group-buying network built by former pharma executives quietly became the largest independent community-oncology network in the country - and why staying small and independent is the whole point.
AcuityMD is a Boston-based commercial intelligence platform built specifically for the medical device (MedTech) industry. It translates large volumes of healthcare claims and procedure data into intuitive workflows, AI-powered insights, and recommendations that help medical device sales and marketing teams find high-value physicians and care sites, size and segment markets, manage territories, and accelerate product adoption. Founded in 2019 by former MedTech and consulting operators, the company serves hundreds of device makers - including a majority of the largest MedTech firms - and raised an $80M Series C in 2026 at a near-$1B valuation.